Empowering People Hurt by Big Businesses

Local (415) 319-8833
Toll Free (855) 534-0061

Blog Posts in January, 2013

  • Drugmaker Amgen Fined For Illegally Marketing Its Anemia Drug

    Drugmaker Amgen is set to pay a $762 million fine for illegally marketing its anemia drug Aranesp for off-label uses that the U.S. Food and Drug Administration specifically ruled out. The New York Times reports that the biotech company agreed to pay the fine to settle criminal penalties and whistleblower lawsuits. Prosecutors allege that the company pushed the sale of its anemia drugs while ...
    Continue Reading
  • Medtronic Infuse Linked To Cauda Equina Syndrome

    Medtronic's Infuse Bone Graft has been associated with some of the most extensive medical device liability cases of the past few years. The Medtronic Infuse Bone Graft is a medical device that is used to replace damaged spinal disks and simulate bone growth. Unfortunately, this device appears to have been inadequately tested before it was released on the market and many patients experienced ...
    Continue Reading
  • Experts Weigh The Risks, Side Effects Of Oral Birth Control Pills

    Regulators around the world are taking a closer look at birth control pills that may expose women to an increased risk of blood clots and strokes. Many product liability lawsuits have arisen out of the newer forms of birth control pills, which are known as third- and fourth-generation pills. Reuters reports that many medical experts consider the newer forms of these pills to be more dangerous than ...
    Continue Reading
  • J&J Study Indicates Shocking Failure Rates In All-Metal Hip Implants

    An internal study done by Johnson & Johnson estimates that the company's all-metal implants have a 37 percent five-year failure rate, according to court documents recently made public. This means that all-metal hip implants are more than seven times more dangerous than traditional hip implants made of metal and plastic. Thousands of Californians have received all-metal hip implantsmanufactured by ...
    Continue Reading
  • Experts Reconsidering The Safety, Efficacy Of Pradaxa

    Health care experts in the United States and abroad are reconsidering the safety and efficacy of the blood thinner Pradaxa. The U.S. Food and Drug Administration recently issued a warning that Pradaxa, or dabigatran etexilate mesylate, was not safe to use in patients with mechanical heart valves. Officials in Australia have also re-evaluated whether the potentially defective pharmaceutical will be ...
    Continue Reading
  • Fda Issues Urgent Warning Regarding Fake Botox

    The U.S. Food and Drug Administration recently issued an urgent warning to 350 medical practices that they may have bought counterfeit Botox from a network of wholesalers operated by CanadaDrugs. The company has also been linked to a series of fake cancer medicines and other defective pharmaceuticals that were likely produced in China. The Wall Street Journal reported that this is the fifth time ...
    Continue Reading
  • Feds Move To Further Restrict The Sale Of All-Metal Hip Implants

    Federal regulators recently announced plans to tighten restrictions on the sale of all-metal hip implants which have been shown to fail at alarming rates sometimes within years of implantation. The U.S. Food and Drug Administration's new proposal would halt the sale and approval of all-metal hip implants until medical device manufacturers can affirmatively show that these devices are safe for ...
    Continue Reading
  • Drugmaker Eli Lilly Settles Foreign Bribery Case

    Drugmaker Eli Lilly & Co. recently agreed to pay $29.9 million to settle a foreign bribery case with the U.S. Securities and Exchange Commission. The SEC alleged that the drugmaker allowed its subsidiaries to bribe officials of foreign countries to award the company millions of dollars in business. Bloomberg News reports that the bribery settlement involves Eli Lilly subsidiaries in China, Russia, ...
    Continue Reading
Page 1 of 1